Elevate Capital Advisors, LLC Eli Lilly & CO Transaction History
Elevate Capital Advisors, LLC
- $108 Billion
- Q1 2025
A detailed history of Elevate Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Elevate Capital Advisors, LLC holds 328 shares of LLY stock, worth $260,799. This represents 0.25% of its overall portfolio holdings.
Number of Shares
328
Previous 340
3.53%
Holding current value
$260,799
Previous $262 Million
3.39%
% of portfolio
0.25%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,395Shares Held
821MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$80.6 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$76.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$63 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$52.4 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$27.4 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $756B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...